1. Home
  2. GAUZ vs ABOS Comparison

GAUZ vs ABOS Comparison

Compare GAUZ & ABOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GAUZ
  • ABOS
  • Stock Information
  • Founded
  • GAUZ 2009
  • ABOS 1996
  • Country
  • GAUZ Israel
  • ABOS United States
  • Employees
  • GAUZ N/A
  • ABOS N/A
  • Industry
  • GAUZ Industrial Machinery/Components
  • ABOS Biotechnology: Pharmaceutical Preparations
  • Sector
  • GAUZ Miscellaneous
  • ABOS Health Care
  • Exchange
  • GAUZ Nasdaq
  • ABOS Nasdaq
  • Market Cap
  • GAUZ 102.0M
  • ABOS 113.9M
  • IPO Year
  • GAUZ 2024
  • ABOS 2021
  • Fundamental
  • Price
  • GAUZ $5.91
  • ABOS $2.26
  • Analyst Decision
  • GAUZ Strong Buy
  • ABOS Strong Buy
  • Analyst Count
  • GAUZ 3
  • ABOS 3
  • Target Price
  • GAUZ $13.67
  • ABOS $8.00
  • AVG Volume (30 Days)
  • GAUZ 31.3K
  • ABOS 448.5K
  • Earning Date
  • GAUZ 11-13-2025
  • ABOS 11-11-2025
  • Dividend Yield
  • GAUZ N/A
  • ABOS N/A
  • EPS Growth
  • GAUZ N/A
  • ABOS N/A
  • EPS
  • GAUZ N/A
  • ABOS N/A
  • Revenue
  • GAUZ $96,810,000.00
  • ABOS N/A
  • Revenue This Year
  • GAUZ $22.59
  • ABOS N/A
  • Revenue Next Year
  • GAUZ $41.48
  • ABOS N/A
  • P/E Ratio
  • GAUZ N/A
  • ABOS N/A
  • Revenue Growth
  • GAUZ 7.87
  • ABOS N/A
  • 52 Week Low
  • GAUZ $4.54
  • ABOS $0.86
  • 52 Week High
  • GAUZ $13.00
  • ABOS $3.36
  • Technical
  • Relative Strength Index (RSI)
  • GAUZ 42.47
  • ABOS 61.87
  • Support Level
  • GAUZ $6.06
  • ABOS $1.85
  • Resistance Level
  • GAUZ $6.59
  • ABOS $2.46
  • Average True Range (ATR)
  • GAUZ 0.40
  • ABOS 0.21
  • MACD
  • GAUZ -0.09
  • ABOS -0.00
  • Stochastic Oscillator
  • GAUZ 13.50
  • ABOS 67.21

About GAUZ Gauzy Ltd. Ordinary Shares

Gauzy Ltd is a fully integrated light and vision control company. Its products include suspended particle device and liquid crystal materials for smart glass applications and AI-powered driver assistance systems, or ADAS, solutions including camera monitoring systems. The company's operating segments are Architecture, Automotive, Safety tech, and Aeronautics. Maximum revenue is generated from its Safety tech segment, which focuses on sales of driver assistance systems for buses, coaches, recreational vehicles, and specific vehicles, such as camera and motion sensor systems, smart mirrors, and safety doors. Geographically, it derives maximum revenue from other European countries (excluding France), followed by the United States, France, Asia, Israel, and other regions.

About ABOS Acumen Pharmaceuticals Inc.

Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.

Share on Social Networks: